Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;41(1):205-207.
doi: 10.1002/hon.3064. Epub 2022 Aug 19.

High mortality in fully vaccinated hematologic patients treated with anti-CD20 antibodies during the "Omicron wave" of COVID-19 pandemic

Chiara Cattaneo  1 , Lorenzo Masina  1 , Chiara Pagani  1 , Valeria Cancelli  1 , Rosa Daffini  1 , Alessandra Tucci  1 , Giuseppe Rossi  1
Affiliations

High mortality in fully vaccinated hematologic patients treated with anti-CD20 antibodies during the "Omicron wave" of COVID-19 pandemic

Chiara Cattaneo et al. Hematol Oncol. 2023 Feb.
No abstract available

Keywords: COVID-19; Omicron wave; hematological malignancies; outcome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

FIGURE 1
FIGURE 1
COVID‐related mortality according to hematologic disease. The black bars refer to mortality rate observed in March 2020; the gray bars to that observed in December 2021 and January 2021 (“Omicron wave”)
See this image and copyright information in PMC

References

    1. Cattaneo C, Daffini R, Pagani C, et al. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID‐19. Cancer. 2020;126(23):5069‐5076. 10.1002/cncr.33160 - DOI - PubMed
    1. Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID‐19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7(10):e737‐e745. 10.1016/S2352-3026(20)30251-9 - DOI - PMC - PubMed
    1. Cattaneo C, Pagani C, Cancelli V, et al. Reduction in the rate and improvement in the prognosis of COVID‐19 in haematological patients over time. Leukemia. 2021;35(2):632‐634. 10.1038/s41375-020-01015-1 - DOI - PMC - PubMed
    1. Pagano L, Salmanton‐García J, Marchesi F, et al. COVID‐19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol. 2021;14(1):168. 10.1186/s13045-021-01177-0 - DOI - PMC - PubMed
    1. Wang L, Berger NA, Kaelber DC, Davis PB, Volkow ND, Xu R. COVID infection rates, clinical outcomes, and racial/ethnic and gender disparities before and after Omicron emerged in the US. medRxiv. 2022. 10.1101/2022.02.21.22271300 - DOI